These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 765571)

  • 1. [Surface antigen of Clostridium botulinum. 3. Isolation and characterization of glycopeptide antigen of E type organism].
    Takumi K; Nagao S; Kawata T
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):83. PubMed ID: 765571
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation of a common cell wall antigen from the proteolytic strains of Clostridium botulinum.
    Takumi K; Kawata T
    Jpn J Microbiol; 1974 Jan; 18(1):85-90. PubMed ID: 4212113
    [No Abstract]   [Full Text] [Related]  

  • 3. Demonstration and characterization of the cell wall carbohydrate and protein antigens from Clostridium botulinum type E Saroma.
    Takumi K; Nagao S; Takeoka A
    Microbiol Immunol; 1991; 35(1):27-37. PubMed ID: 1908039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemical characterization of cell wall protein antigen purified from the cell wall autolysate of Clostridium botulinum type A.
    Takumi K; Kawata T
    Jpn J Microbiol; 1975 Feb; 19(1):1-6. PubMed ID: 51110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of a wall protein antigen from Clostridium botulinum type A.
    Takumi K; Takeoka A; Kawata T
    Infect Immun; 1983 Mar; 39(3):1346-53. PubMed ID: 6341236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural changes associated with extraction of group E spore antigen of Clostridium botulinum.
    Hawirko RZ; Chung KL; Magnusson AJ; Emeruwa AC
    J Bacteriol; 1972 Dec; 112(3):1416-9. PubMed ID: 4565544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antigenicity of Clostridium botulinum type C toxin administered per os.
    Jansen BC; Knoetze PC; Visser F
    Onderstepoort J Vet Res; 1970 Sep; 37(3):169-71. PubMed ID: 4949136
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemiluminescence immunosorbent assay (CLISA) and a possibility of the specific detection of soluble antigens of Clostridium botulinum type A.
    Ligieza J; Reiss J; Michalik M
    Arch Immunol Ther Exp (Warsz); 1994; 42(2):129-33. PubMed ID: 7503646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization, self-assembly and reattachment of S layer from Clostridium botulinum type E saroma.
    Takumi K; Ichiyanagi S; Endo Y; Koga T; Oka T; Natori Y
    Tokushima J Exp Med; 1992 Dec; 39(3-4):101-7. PubMed ID: 1295126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antigenic variations in F type botulinum toxins. Attempted definitions by serological typing and classification of Clostridium botulinum].
    Gimenez DF; Ciccarelli AS
    Medicina (B Aires); 1972; 32(6):596-606. PubMed ID: 4576316
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigenic hemagglutination inhibition test in examining of the culture supernatants of Clostridium botulinum types A, B, E, and F and some related bacterial species.
    Reiss J; Wojtyła B; Lipko A
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):531-9. PubMed ID: 6200089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of soluble antigens of Clostridium botulinum A by chemiluminescent--immunosorbent assay (CLISA).
    Ligieza J; Michalik M; Reiss J; Grzybowski J
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):189-95. PubMed ID: 2431667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking of antibody passive hemagglutination reaction (Bl-AbHAp) as a test for in vitro recognition of type-specific soluble antigens of Clostridium botulinum.
    Ligieza J; Reiss J
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):183-7. PubMed ID: 3539066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of soluble antigens of type E Clostridium botulinum by gel diffusion].
    Rymkiewicz D; Albrycht H
    Med Dosw Mikrobiol; 1965; 17(4):291-7. PubMed ID: 4956463
    [No Abstract]   [Full Text] [Related]  

  • 15. [Problem of non-soluble antigens in the identification of Cl. botulinum. I. Precipitation and immunofluorescence studies].
    Cygan Z
    Pol Arch Weter; 1972; 15(2):245-64. PubMed ID: 4572437
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of botulinum toxin type by the reaction of indirect hemagglutination inhibition.
    Reiss J; Wojtyła B
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):97-108. PubMed ID: 7025794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of hemagglutinin of Clostridium botulinum type C strain Stockholm.
    Suzuki N; Syuto B; Kubo S
    Jpn J Vet Res; 1986 Oct; 34(3-4):269-78. PubMed ID: 3546890
    [No Abstract]   [Full Text] [Related]  

  • 18. [Insoluble antigens in the identification of Cl. botulinum. II. Agglutination and hemagglutination studies and complement fixation reaction].
    Cygan Z
    Pol Arch Weter; 1973; 16(1):47-64. PubMed ID: 4132768
    [No Abstract]   [Full Text] [Related]  

  • 19. [Insoluble antigens in the identification of Cl. botulinum. 3. Chemical studies of polysaccharides].
    Cygan Z
    Pol Arch Weter; 1973; 16(1):65-83. PubMed ID: 4596012
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serological properties of the soluble spore antigens of Clostridium botulinum].
    Rymkiewicz D
    Med Dosw Mikrobiol; 1971; 23(4):313-9. PubMed ID: 5003807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.